Prenatal Vitamins & Supplements

Why This Guide Exists

Prenatal vitamins occupy a strange position in the American market. They are sold as essential supplements for pregnancy, recommended by virtually every obstetric clinician, featured prominently in every What to Expect-style resource, and yet they are regulated not as drugs but as dietary supplements under the Dietary Supplement Health and Education Act of 1994 (DSHEA). That single legislative fact shapes everything downstream: manufacturers are not required to demonstrate safety or efficacy before selling, labels need not be verified by any independent body, and the FDA can only intervene after harm has already occurred and been documented well enough to trigger enforcement action.

The practical result was documented in stark terms by two landmark reports published in 2023 and 2024. A 2023 U.S. Government Accountability Office analysis tested twelve over-the-counter prenatal supplements and found that eleven of the twelve deviated from their label declaration in at least one nutrient -- some exceeding declared amounts by more than thirty percent, others falling below eighty percent. A 2024 study published in Environmental Research tested a broad sample of over-the-counter prenatals and found that 83% contained detectable lead, 73% contained detectable cadmium, more than 25% contained detectable phthalates, and 15% exceeded California Proposition 65's 0.5 micrograms-per-serving lead threshold. These are not trace elements from the surrounding environment -- they are contaminants that enter through the raw mineral ingredients that supply calcium, iron, and zinc in the most common supplement formulations.

At the same time, prenatal nutrition genuinely matters. The evidence base for periconceptional folate supplementation in neural tube defect prevention is among the strongest in all of nutritional epidemiology. Adequate iodine during pregnancy supports fetal thyroid development in a window that cannot be compensated for later. Iron deficiency anemia in pregnancy is associated with preterm birth and low birth weight. Choline is increasingly recognized as essential for fetal brain development, yet it is absent or present at negligible levels in the majority of prenatal supplements currently on the market. A well-chosen prenatal can meaningfully fill dietary gaps; a poorly chosen one can introduce contaminant exposures while delivering nutrients at doses that bear little relationship to what is printed on the label.

This guide synthesizes the clinical evidence for individual nutrients, the contamination and mislabeling data, the regulatory framework and its limits, the significance of nutrient form (not just amount), the herbs that are genuinely dangerous during pregnancy, and the third-party verification systems that provide meaningful quality signals in an unregulated market.

Product Categories

The prenatal supplement market spans a wide range of product types that differ in regulatory status, manufacturing standards, nutrient form choices, and what they can and cannot deliver. Understanding the category you are shopping in matters as much as reading any individual label.

1. Prescription Prenatals

Prescription prenatal vitamins are manufactured under pharmaceutical current Good Manufacturing Practices (cGMP), which are substantially more rigorous than the supplement cGMP standards that govern over-the-counter products. They require identity testing for every incoming ingredient batch, potency testing of the finished product, and documented deviation reporting. They are covered by most insurance plans and fully covered by Medicaid, which is a meaningful cost consideration for many families. The trade-off is that prescription formulations are not automatically superior in nutrient form -- some use folic acid where 5-MTHF would be preferred, and iron forms vary by brand. A prescription label does not guarantee a particular nutrient form; it guarantees a higher manufacturing standard.

2. Over-the-Counter Standard Prenatals

The largest segment of the market, ranging from national pharmacy brands to specialty supplement brands. Quality within this category varies enormously. The 2023 GAO study and the 2024 Environmental Research contamination study both drew primarily from this segment. Some OTC prenatals have undergone rigorous third-party testing and publish certificates of analysis; many have not. The presence of a USP Verified or NSF Certified seal on an OTC prenatal is a meaningful signal that distinguishes verified products from unverified ones.

3. Gummy Prenatals

Gummy prenatals are the fastest-growing format in this category, driven by palatability for those experiencing nausea or tablet aversion. The fundamental trade-off is this: the sugar, pectin, and water content of a gummy limits how many active ingredients can fit in the serving size, and iron cannot be included because it reacts with the gummy matrix and produces an unacceptable taste. Most gummies contain zero iron or only nominal amounts. For anyone whose prenatal is their primary iron source -- which describes the majority of pregnant people -- a gummy-only prenatal is insufficient for iron needs. Gummies may be useful as a bridge when nausea makes tablets impossible, but should typically be paired with a separate iron supplement or confirmed against dietary iron intake.

4. Whole-Food and Plant-Based Prenatals

"Whole-food form," "food-grown," and "food-matrix" prenatals are marketed on the premise that nutrients derived from or bound to food substrates are more bioavailable than synthetic forms. The evidence base for superior bioavailability in this category is inconsistent -- some food-matrix nutrients do perform equivalently, and the claims about enhanced absorption are often broader than the supporting data. What is reliably true is that many whole-food prenatals use lower doses of individual nutrients than conventional prenatals, and that verification of actual nutrient content is rare. For certain nutrients (particularly iron and folate), confirmed adequate dosing matters more than source claims. Whole-food prenatals that carry a USP or NSF seal and meet the clinical dosing targets are a reasonable choice; those that do not verify content and rely solely on "food-form" marketing language warrant skepticism about whether the doses are adequate.

5. Methylated Prenatals

Methylated or "MTHFR-aware" prenatals replace folic acid with 5-methyltetrahydrofolate (5-MTHF, the bioactive form) and often replace cyanocobalamin with methylcobalamin. This category has grown rapidly alongside consumer awareness of MTHFR genetic variants, which reduce the enzyme activity needed to convert folic acid to its active form. The rationale for 5-MTHF is legitimate for individuals who have confirmed MTHFR variants, and 5-MTHF bypasses the conversion step regardless of MTHFR status, making it a broadly reasonable choice. The concern with this segment is that some methylated prenatals are priced at a significant premium while providing no third-party verification of label accuracy or heavy-metal testing -- the methylation story can become cover for skipping the verification steps that actually matter.

6. Single-Nutrient Supplements

Standalone DHA, standalone iron, standalone folate, and standalone choline supplements are increasingly used either to supplement an existing prenatal that is deficient in one nutrient, or to build a custom prenatal stack. This approach allows precise selection of nutrient form and dose for each nutrient independently, but requires more management and introduces more opportunity for dosing errors or interactions. Clinician guidance is particularly useful when building a multi-supplement approach. Single-nutrient products are also useful when a specific clinical need is identified -- for example, adding algal DHA to a prenatal that contains no omega-3s, or adding bisglycinate iron when a standard iron supplement is causing intolerable GI side effects.

7. Postpartum and Lactation Formulas

Postpartum or lactation-specific prenatals adjust the nutrient profile for the breastfeeding period, typically reducing iron (blood loss is lower; dietary absorption from food is often sufficient) and increasing iodine (to 290 mcg for lactation, versus 220 mcg during pregnancy), choline, and sometimes vitamin D. DHA needs remain elevated through breastfeeding. These products are appropriate for the lactation window but should not replace a prenatal during pregnancy itself, since iron and folate doses may be lower than pregnancy requirements.

Categories at a Glance

Core Nutrients: What You Actually Need and Why

Nutritional requirements shift substantially during pregnancy. The following are the nutrients where supplementation has the clearest clinical rationale. Doses listed are the current U.S. Dietary Reference Intakes (DRI) for pregnancy unless otherwise noted; some nutrients have significant clinical practice variation above the DRI floor.

1. 01

   Folate -- 600 mcg DFE/day (periconceptional 400-800 mcg)

   Neural tube closure occurs between days 18 and 28 post-conception -- before most people know they are pregnant. The evidence that periconceptional folic acid supplementation reduces NTD risk by approximately 50-70% is among the strongest in nutritional epidemiology (MRC Vitamin Study, 1991; Czeisel and Dudas, 1992). The current recommendation is 400 mcg/day starting at least one month before conception and through the first trimester, increasing to 600 mcg DFE during pregnancy. Women with a prior NTD-affected pregnancy are typically advised by their clinician to take 4 mg (4,000 mcg) per day -- a dose that requires prescription or deliberate high-dose supplementation. Dietary folate equivalents (DFE) account for the lower bioavailability of naturally occurring food folate versus synthetic supplemental folic acid; 1 mcg of synthetic folic acid equals approximately 1.7 mcg DFE.

2. 02

   Iron -- 27 mg/day (versus 18 mg non-pregnant)

   Blood volume increases by approximately 50% during pregnancy and fetal iron stores are built almost entirely from maternal circulation. The RDA rises from 18 mg to 27 mg during pregnancy. Iron deficiency anemia -- which affects roughly 18% of pregnant people in the U.S. by the third trimester -- is associated with preterm birth, low birth weight, and postpartum depression. Most prenatal vitamins provide 27 mg of iron, but the form varies significantly in its tolerability and bioavailability. Constipation and nausea are the primary reasons people skip doses or abandon their prenatal; iron form selection is a direct lever on adherence.

3. 03

   Calcium -- 1,000 mg/day

   The fetal skeleton requires approximately 250-300 mg of calcium per day in the third trimester alone. If maternal intake is insufficient, maternal bone provides a buffer. Most prenatal vitamins provide only 100-200 mg of elemental calcium because providing the full daily target (1,000 mg) would require a pill the size of a large lozenge. The gap between what a prenatal provides and what pregnancy requires is typically filled by dietary sources -- dairy, fortified plant milks, and dark leafy greens. Three servings of dairy or fortified equivalent per day typically provide 900-1,000 mg. Calcium supplementation above dietary intake may be warranted in vegan/dairy-free diets, but should be confirmed with the clinician because high-dose calcium supplements can interfere with iron absorption and have been associated with cardiovascular considerations at very high intake in non-pregnant populations.

4. 04

   Vitamin D -- 600 IU/day RDA (600-2,000 IU common clinical practice)

   Vitamin D is essential for calcium absorption, immune function, and fetal bone development. The official RDA for pregnancy is 600 IU/day, but many obstetric practitioners routinely recommend higher doses (1,000-2,000 IU) because widespread insufficiency in the general population (particularly in northern latitudes, indoor workers, and people with darker skin) means that the RDA is inadequate to achieve sufficient serum 25-OH-D levels for a substantial fraction of pregnant people. The Tolerable Upper Intake Level is 4,000 IU/day from all sources; toxicity is rare below that threshold. D3 (cholecalciferol) is the preferred form -- it raises serum 25-OH-D levels approximately 1.7 times more effectively than D2 (ergocalciferol) at equivalent doses.

5. 05

   Iodine -- 220 mcg/day pregnancy, 290 mcg/day lactation

   Iodine is required for maternal thyroid hormone synthesis, which drives fetal brain development -- particularly in the first trimester before the fetal thyroid is functional. Iodine deficiency is the leading preventable cause of intellectual disability worldwide. In the United States, iodine status has declined since the 1970s as iodized salt use has decreased; surveys find that approximately 17% of pregnant women in the U.S. have urinary iodine concentrations suggesting inadequacy. Vegetarians and people who use sea salt (which is not iodized) are at elevated risk. Approximately 40% of U.S. prenatal vitamins do not contain iodine or contain less than the RDA; confirmation that a prenatal contains at least 150 mcg of iodine (ideally from potassium iodide rather than kelp, which has variable iodine content) is important.

6. 06

   Choline -- 450 mg/day (Adequate Intake)

   Choline is essential for fetal brain development, particularly hippocampal development and memory function. A 2018 randomized controlled trial found that supplementing with 930 mg/day of choline (approximately double the AI) during the third trimester produced measurable improvements in infant cognitive performance at seven and ten months of age. Despite this evidence, only about 10% of pregnant women in the U.S. meet the choline AI from diet alone, and the majority of prenatal vitamins provide little or no choline -- a 2019 analysis found that 92% of prenatal vitamins provided less than 55 mg of choline, versus the 450 mg daily target. Eggs and meat are the primary dietary sources (one egg provides approximately 147 mg). Vegans and vegetarians are at substantially elevated risk for choline insufficiency and should prioritize supplementation. Choline supplementation as choline bitartrate or CDP-choline alongside a prenatal is worth discussing with a clinician.

7. 07

   DHA (omega-3) -- 200-300 mg/day

   Docosahexaenoic acid (DHA) is the primary omega-3 fatty acid in the fetal brain and retina, and approximately 60% of the brain's dry weight is fat -- with DHA making up the largest share. The fetal brain accumulates DHA at the highest rate during the third trimester and through the first two years of life. The American College of Obstetricians and Gynecologists recommends 200-300 mg/day of DHA during pregnancy. Despite this, only approximately 15% of OTC prenatal vitamins include adequate DHA. Fish consumption provides the most efficient dietary source, but the FDA and EPA advise limiting high-mercury fish (swordfish, king mackerel, tilefish, shark, bigeye tuna) during pregnancy -- leaving fatty fish like salmon, sardines, and trout as the recommended dietary sources. Algal oil DHA (derived from the same algae that fish consume) is a fully equivalent vegan source that carries no mercury or PCB risk and is appropriate for all pregnancies.

8. 08

   Vitamin B12 -- 2.6 mcg/day

   B12 is required for DNA synthesis and neurological function. Deficiency during pregnancy is associated with NTDs, preterm birth, and infant neurodevelopmental delays. Dietary B12 is found exclusively in animal products (meat, fish, dairy, eggs); vegans and strict vegetarians are at significant risk for deficiency without supplementation. Standard prenatal doses (2.6-12 mcg) are adequate for most people, but absorption from supplements can be inconsistent at higher doses due to intrinsic factor saturation; some clinicians prefer methylcobalamin over cyanocobalamin for people with known absorption concerns or MTHFR variants. B12 has no established Upper Tolerable Intake Level -- supplemental doses from 2.6 mcg to several hundred mcg are considered safe.

9. 09

   Vitamin B6 -- 1.9 mg/day (higher doses used clinically for nausea)

   Pyridoxine (B6) supports amino acid metabolism and fetal brain development. At the standard prenatal dose of 1.9-2.5 mg/day, it functions as a general nutrient. At higher supplemental doses of 10-25 mg three times daily, it has clinical evidence for reducing the severity of nausea and vomiting in pregnancy (NVP) -- and forms the active component of doxylamine-pyridoxine combination products (Diclegis/Bonjesta). The Upper Tolerable Intake Level for B6 is 100 mg/day from all sources; peripheral neuropathy has been reported with chronic high-dose use above this threshold. For nausea management specifically, supplemental B6 at 10-25 mg per dose is within the safety window and supported by the ACOG NVP treatment guidelines.

10. 10

    Other nutrients: zinc, magnesium, vitamin C, vitamin E, selenium

    Zinc (11 mg/day during pregnancy) supports cell division and immune function; most prenatals provide adequate zinc. Magnesium requirements increase to 350-360 mg/day; many prenatals provide minimal magnesium because it adds bulk, and dietary sources (leafy greens, nuts, legumes, whole grains) fill most of the gap. Vitamin C (85 mg/day) supports collagen synthesis and iron absorption; requirements are modestly elevated over the non-pregnant baseline. Vitamin E (15 mg/day) functions as an antioxidant; excess supplementation above the 1,000 mg UL has been associated with adverse outcomes in older intervention studies and should be avoided. Selenium (60 mcg/day) supports thyroid function and antioxidant defense; requirements rise modestly in pregnancy. All of these are typically present in standard multivitamin prenatals at appropriate levels.

Vitamin A and Teratogenicity: The One Nutrient With a Documented Upper Limit

Vitamin A is the single nutrient in the prenatal supplement context with a well-documented dose-dependent teratogenic risk at doses commonly found in over-the-counter supplements. The distinction between vitamin A forms -- preformed retinol versus provitamin A beta-carotene -- is not marketing language; it reflects a fundamentally different biological pathway and an entirely different risk profile.

Preformed retinol (listed on supplement labels as retinyl acetate, retinyl palmitate, or vitamin A as retinol) is absorbed directly and enters the circulation as retinol. The body has limited capacity to downregulate preformed retinol absorption; excess retinol is stored in the liver and can accumulate. The landmark Rothman et al. 1995 New England Journal of Medicine study followed 22,748 pregnant women enrolled in the Nurses' Health Study and found a clear dose-response relationship between supplemental preformed vitamin A intake and cranial-neural-crest malformations in offspring. Women who consumed more than 10,000 IU per day of preformed vitamin A from supplements had a relative risk of approximately 4.8 for cranial neural crest defects compared to those taking 5,000 IU or less. The types of defects observed included cleft palate, ear and eye abnormalities, and conotruncal heart defects -- consistent with the known role of retinoic acid in neural crest cell migration. A separate cohort analysis estimated that about 1 in 57 infants born to mothers taking more than 10,000 IU daily had a vitamin A-related malformation.

Beta-carotene (listed as beta-carotene or provitamin A carotenoid) is converted to retinol by intestinal enzymes, and the conversion rate is tightly regulated by the body's retinol status -- the higher the existing retinol level, the lower the conversion rate. No teratogenic risk has been demonstrated for any dose of beta-carotene supplementation; the body will not over-convert even at very high supplemental intake. Beta-carotene at any dose in prenatal vitamins is therefore safe from a teratogenicity standpoint.

To evaluate a prenatal's vitamin A source, read the Supplement Facts panel carefully. Look for "Vitamin A (as beta-carotene)" -- this is the safest form. If the label says "Vitamin A (as retinyl acetate)" or "retinyl palmitate," note the IU amount: 2,500-5,000 IU of preformed retinol is in the acceptable range; any amount above 5,000 IU of preformed retinol warrants caution, particularly for first-trimester use when organogenesis is occurring. The safest prenatals provide 100% of their vitamin A as beta-carotene or omit preformed retinol entirely.

Nutrient Forms Matter: Not All Versions of the Same Nutrient Are Equivalent

Labels report nutrient names; they rarely explain which chemical form is being used or why the form choice matters. For several key nutrients, the form is as important as the dose.

Folate: Folic Acid vs. 5-MTHF

Folic acid (pteroylglutamic acid) is a synthetic form that must be converted in the body through a multi-step pathway involving the enzyme methylenetetrahydrofolate reductase (MTHFR) before it can be used in DNA synthesis and methylation. 5-methyltetrahydrofolate (5-MTHF or methylfolate) is the biologically active form that exists at the end of that pathway and enters directly into cellular use without requiring MTHFR activity.

The MTHFR C677T and A1298C single-nucleotide polymorphisms reduce MTHFR enzyme activity -- by approximately 35% in those with one C677T copy (heterozygous) and by approximately 70% in those with two copies (homozygous). Population studies estimate that approximately 10-15% of people of European descent are homozygous C677T, and that 30-40% of the U.S. population carries at least one copy of one of these variants. For individuals with reduced MTHFR activity, 5-MTHF provides the active form directly and bypasses the enzymatic bottleneck.

A secondary concern with high-dose folic acid specifically is unmetabolized folic acid (UMFA). When folic acid intake substantially exceeds MTHFR enzymatic capacity, folic acid appears unmetabolized in the bloodstream. This has been associated in preclinical studies with potential interference with natural killer cell function and possible masking of B12 deficiency. The practical implication: 5-MTHF avoids the UMFA accumulation issue entirely, regardless of MTHFR genotype, because it does not require conversion. Both forms prevent NTDs at adequate doses in clinical trials; 5-MTHF at 400-800 mcg is a broadly reasonable choice for any prenatal.

Iron: Sulfate, Fumarate, and Bisglycinate

The majority of OTC prenatal vitamins use ferrous sulfate (27 mg is standard). Ferrous sulfate is the most prescribed form, has the longest safety record, and is the form against which others are benchmarked. It is also the form most frequently associated with constipation, nausea, and dark stools. Ferrous fumarate is an intermediate form with slightly better tolerability than sulfate. Ferrous bisglycinate (iron bisglycinate chelate, also marketed as "gentle iron") is a chelated form in which iron is bound to two glycine amino acid molecules. The glycine chelation protects the iron from forming reactive species in the gut and appears to reduce the pro-oxidative GI irritation that produces most iron's side effects. A 2024 randomized controlled trial published in the Journal of Pregnancy directly compared ferrous sulfate, ferrous fumarate, and ferrous bisglycinate at equivalent doses in pregnant women and found that bisglycinate produced significantly fewer GI side effects with equivalent hemoglobin response at 12 weeks. Since iron supplement intolerance is the primary reason prenatals are abandoned, bisglycinate is the form most likely to support consistent adherence.

Vitamin D: D3 vs. D2

Vitamin D3 (cholecalciferol, from animal or lichen sources) raises serum 25-hydroxyvitamin D levels approximately 1.7 times more effectively than D2 (ergocalciferol, from plant/fungal sources) at equivalent supplemental doses. D3 is the preferred form for prenatal supplementation. Vegan D3 derived from lichen is available and provides equivalent efficacy to animal-sourced D3.

B12: Cyanocobalamin vs. Methylcobalamin

Cyanocobalamin is the most stable and inexpensive form; it requires conversion to methylcobalamin or adenosylcobalamin before use. Methylcobalamin is the active form and may be preferable for MTHFR carriers or those with impaired conversion. At typical prenatal doses (4-12 mcg), the form difference has limited clinical significance for most people. For high-dose B12 supplementation or for confirmed B12 deficiency in pregnancy, methylcobalamin is the preferred form.

Calcium: Citrate vs. Carbonate

Calcium carbonate (the most common form in supplements) contains more elemental calcium per gram and is less expensive, but requires stomach acid for dissolution and absorption -- meaning it should be taken with food. Calcium citrate does not require acid and can be taken with or without food, making it the preferred form for those using proton pump inhibitors, H2 blockers, or anyone who has had gastric surgery. When iron and calcium are both being supplemented, they should be separated by at least two hours, as calcium inhibits iron absorption.

DHA: Fish Oil vs. Algal Oil

Fish oil DHA (typically in ethyl ester or triglyceride form) and algal oil DHA both raise serum DHA levels adequately. Triglyceride-form fish oil is generally considered better absorbed than ethyl ester form. Algal oil DHA is vegan, carries no mercury or PCB exposure, and is the source from which fish accumulate their DHA in the first place -- it is a functionally identical source. For pregnant people concerned about contaminants in fish-derived products, algal DHA is the lowest-risk choice with equivalent efficacy.

Contamination Data: What Independent Testing Has Found

The 2024 Environmental Research study and 2023 GAO report provided the most comprehensive published data on contamination and mislabeling in the prenatal supplement market. The following summarizes the primary contaminant categories identified and their routes of entry into the supplement matrix. The finding that applies to nearly every contaminant below is the same: they enter predominantly through the raw mineral ingredients that constitute the bulk of a prenatal tablet -- calcium carbonate from mined limestone, ferrous compounds, and zinc oxide -- all of which carry naturally occurring heavy metal co-contaminants from their geological sources.

1. 01 Lead

   The most prevalent heavy metal found in the 2024 Environmental Research screening: 83% of tested OTC prenatals contained detectable lead, and 15% exceeded California Proposition 65's Maximum Allowable Dose Level of 0.5 mcg/serving. Lead has no known safe blood level during pregnancy. Exposure is associated with impaired fetal neurodevelopment, reduced IQ, preterm birth, and low birth weight. The primary entry route into prenatal vitamins is calcium carbonate (sourced from mined limestone, which naturally contains lead co-contaminants), and to a lesser extent, iron and zinc mineral ingredients. California SB 646, signed October 2025 and effective January 1, 2027, will require prenatal vitamin manufacturers selling in California to test for heavy metals and disclose results -- the first such law in the country.

2. 02 Cadmium

   Detected in 73% of OTC prenatals tested in the 2024 Environmental Research study. Cadmium is a nephrotoxin that accumulates in the renal cortex over a lifetime; it also disrupts calcium metabolism, reduces bone mineral density, and crosses the placenta. Like lead, it enters prenatal supplements primarily through calcium carbonate and mineral ingredient sourcing. Cadmium has a biological half-life of 10-30 years in the human body, meaning gestational exposures contribute to long-term maternal burden as well as fetal exposure.

3. 03 Arsenic (inorganic)

   Detectable in a subset of tested prenatals, with higher concentrations in products containing rice-derived ingredients (rice bran, rice concentrate) or seaweed/kelp-based iodine sources. The critical distinction is between inorganic arsenic (the carcinogenic and developmentally toxic form) and organic arsenobetaine (found in seafood, generally considered non-toxic at low concentrations). Prenatal supplements that use kelp for iodine rather than potassium iodide are at elevated risk for inorganic arsenic contamination because many kelp products contain elevated inorganic arsenic from marine sediment accumulation.

4. 04 Mercury

   Mercury enters prenatal supplements primarily through fish-derived ingredients -- fish oil (for DHA), fish gelatin capsule shells, and fish collagen. Methylmercury is the developmental neurotoxin of primary concern; it crosses the placenta and the blood-brain barrier and accumulates preferentially in fetal neural tissue. Fish oil products that are molecularly distilled and tested for mercury (IFOS 5-Star certification is the standard) contain negligible methylmercury. Algal DHA contains no mercury because it is derived from the primary producer in the marine food chain, not from fish that have bioaccumulated it.

5. 05 Phthalates (DEHP, DBP)

   More than 25% of OTC prenatals in the 2024 Environmental Research study contained detectable phthalates, specifically DEHP (di(2-ethylhexyl) phthalate) and DBP (dibutyl phthalate). The entry routes include plastic processing equipment in manufacturing, plastic packaging that contacts the capsule or tablet surface, and -- specifically for DBP -- enteric coating formulations. Enteric coatings designed to improve tolerability by preventing dissolution in the stomach have historically used DBP as a plasticizer; some coating formulations have migrated away from phthalate-based plasticizers, but the shift is not universal. DEHP is a reproductive and developmental toxicant at documented human-relevant exposures; both are classified as reproductive toxicants under California Proposition 65.

6. 06 Excess Preformed Vitamin A

   As detailed in the vitamin A section above, preformed retinol above approximately 10,000 IU/day is a documented teratogen. Some prenatal vitamins contain 5,000 IU of preformed retinol as retinyl acetate or palmitate -- not a contamination issue from a manufacturing standpoint, but a formulation choice that, when combined with dietary retinol from fortified foods or supplements like cod liver oil, can approach or exceed the threshold associated with cranial neural crest defects. Check the Supplement Facts panel explicitly for the form and dose of vitamin A before selecting a prenatal.

7. 07 Unmetabolized Folic Acid (UMFA)

   At folic acid doses substantially above what the MTHFR enzyme can process, synthetic folic acid circulates in blood in its unmetabolized form. Population biomonitoring studies using NHANES data have found detectable UMFA in a significant proportion of childbearing-age adults in the United States, particularly after mandatory fortification and widespread supplementation. The clinical significance of UMFA remains under active investigation; preclinical studies have raised signals about natural killer cell activity and potential masking of B12 deficiency. The practical consideration: switching to 5-MTHF eliminates this issue, and 5-MTHF supports the same NTD-prevention outcome. Consumers who prefer to use folic acid should stay at or near the 400-800 mcg range rather than high-dose formulations.

8. 08 Undeclared Allergens and Adulterants

   Fish gelatin is commonly used to manufacture soft-gel capsules, including DHA supplements marketed as non-fish or plant-based. DNA barcoding and protein immunoassay testing of supplement products has repeatedly identified undeclared fish protein in products labeled as free of fish. Cross-contamination with soy, wheat, or dairy allergens occurs in multi-product manufacturing facilities. For individuals with allergies, third-party allergen verification or direct manufacturer contact regarding dedicated manufacturing lines is warranted. The 2023 GAO report also identified products where nutrient amounts deviated from label by more than 20% in both directions -- excess selenium was one finding; selenium toxicity begins at chronic supplemental intake above 400 mcg/day, a level some products exceeded.

9. 09 Misdosed Nutrients (Label Inaccuracy)

   The 2023 GAO report tested twelve prenatal supplements and found eleven deviated from their label in at least one nutrient. Deviations included some products containing more than 130% of their declared nutrient amount and others containing less than 80%. Both directions create clinical issues during pregnancy: under-delivery of iron, folate, or iodine creates deficiency risk in a period when those nutrients are critical; over-delivery of vitamins with known upper limits (vitamin A as retinol, selenium, vitamin D at very high doses) creates toxicity risk. This is the foundational argument for requiring third-party verification -- the label alone, without independent testing, cannot be relied upon for dose accuracy.

Contaminants at a Glance

The Regulatory Gap

Understanding why the contamination and mislabeling data above is possible -- and predictable -- requires understanding how the regulatory framework for dietary supplements works, and specifically how it differs from the drug approval framework.

DSHEA 1994: The Foundation

The Dietary Supplement Health and Education Act of 1994 established the current regulatory framework. Under DSHEA, dietary supplements -- including prenatal vitamins -- are classified as food, not drugs. This means manufacturers do not need to demonstrate safety or efficacy before bringing a product to market. They are responsible for ensuring their products are safe, but the burden of proof rests on the FDA to demonstrate that a product is unsafe before taking enforcement action. In the twenty-plus years since DSHEA was enacted, the FDA has had the resources to take enforcement action against a small fraction of the products on the market in any given year.

Current Good Manufacturing Practices (cGMP) -- 21 CFR Part 111

Since 2010, supplement manufacturers have been required to comply with dietary supplement current Good Manufacturing Practices under 21 CFR Part 111. cGMP requires manufacturers to test the identity, purity, strength, and composition of their raw ingredients and finished products. However, there are no specific federal limits for heavy metals like lead and cadmium in dietary supplements (the FDA has proposed but not finalized guidance), and manufacturers are required to test for what they choose to test for -- there is no mandatory contaminant testing panel analogous to what pharmaceutical manufacturers must perform. FDA inspections of supplement facilities have documented frequent and significant cGMP violations. A 2022 FDA summary found violations in roughly a third of inspected supplement facilities.

California SB 646

California Senate Bill 646 was signed into law in October 2025 and takes effect January 1, 2027. It is the first state law in the country to require routine heavy-metal testing and public disclosure specifically for prenatal multivitamin supplements. Under SB 646, manufacturers selling prenatal multivitamins in California must conduct or commission independent testing for lead, cadmium, arsenic, and mercury, and must make the test results publicly accessible on a product webpage. Products that exceed specified thresholds must be reformulated or removed from sale. The law applies to any prenatal multivitamin sold in California regardless of where it is manufactured. Its passage reflects the policy conclusion that the federal regulatory framework is insufficient for this specific population segment -- products consumed during one of the most developmentally sensitive periods of life.

FDA Recalls and Enforcement Actions

Between 2020 and 2024, the FDA issued multiple enforcement actions and recalls affecting prenatal vitamins, including: Class II recalls for undeclared allergens in DHA softgels marketed as allergen-free; Warning Letters for cGMP violations including inadequate finished-product testing; and import alerts for facilities with documented manufacturing deficiencies. The recall system is reactive -- products must already be in the hands of consumers before a problem is typically identified. Consumer reporting through the FDA's MedWatch system and the Dietary Supplement Adverse Event Reporting (DSAERS) system is voluntary and estimated to capture only 1-10% of actual adverse events.

Third-Party Certifications and What They Actually Verify

Because the regulatory framework does not require pre-market independent testing, third-party verification fills the gap between manufacturer claims and independently confirmed product quality. Not all seals are equivalent, and several marks visible on prenatal packaging convey little or no verified information.

Certifications at a Glance

Herbals to Avoid During Pregnancy

Herbal supplements are regulated under the same DSHEA framework as prenatal vitamins -- no pre-market safety demonstration required. This matters especially during pregnancy because a meaningful number of herbs used in traditional medicine, in commercial prenatal teas, and in "whole-food blend" prenatal formulas have documented uterotonic, teratogenic, hepatotoxic, or anticoagulant activity. The phrase "natural" does not mean safe during pregnancy; the dose-response and mechanism considerations that make a compound dangerous are not altered by whether it comes from a plant. The following categories summarize the primary risks.

Uterine Stimulants -- Avoid Throughout Pregnancy

• Blue cohosh (Caulophyllum thalictroides): Contains caulosaponin and caulophyllosaponin, which are uterotonic; also contains N-methylcytisine, a nicotinic receptor agonist that can cause fetal bradycardia and cardiac ischemia. Neonatal toxicity cases have been published in the medical literature. No safe dose in pregnancy has been established; avoid entirely.
• Black cohosh (Actaea racemosa): Evidence of uterotonic activity; ACOG advises against use in pregnancy. Widely used for menopausal symptoms; sometimes included in "women's formula" blends. Check all herbal supplement ingredient lists carefully.
• Pennyroyal (Mentha pulegium): Used historically as an abortifacient. The volatile oil pulegone is metabolized to a hepatotoxic epoxide; fatalities from intentional use as an abortifacient have been reported. Avoid entirely at any dose.
• Dong quai (Angelica sinensis): Widely used in traditional Chinese medicine; contains ferulic acid and other compounds with anticoagulant and uterotonic activity. Frequently combined with other herbs in commercial "fertility" or "women's health" products. Avoid during pregnancy.
• Mugwort (Artemisia vulgaris): Traditional emmenagogue (used to stimulate or regulate menstruation); contains thujone and other artemisia-species compounds with uterotonic properties. Also a common allergen (cross-reactive with birch pollen and celery). Avoid during pregnancy.

Hepatotoxic Herbs -- Avoid Entirely

• Kava (Piper methysticum): Liver toxicity documented in dozens of published case reports; FDA advisory issued in 2002. Risk is particularly elevated with alcoholic extracts. No pregnancy safety data; hepatotoxicity risk is a separate reason to avoid.
• Comfrey (Symphytum officinale): Pyrrolizidine alkaloids cause veno-occlusive liver disease (Budd-Chiari syndrome) and are genotoxic and carcinogenic. Banned from oral products in many countries; found in some traditional herbal preparations. Avoid entirely.
• Greater celandine (Chelidonium majus): Hepatotoxicity documented through multiple spontaneous reporting systems; European Medicines Agency issued a warning on hepatotoxic risk. Avoid during pregnancy.

Hormonally Active Herbs -- Use With Caution or Avoid

• Licorice root (Glycyrrhiza glabra): Glycyrrhizin inhibits 11-beta-hydroxysteroid dehydrogenase, leading to glucocorticoid-like systemic effects. A Finnish prospective cohort study (Raikkonen et al., 2017) found that high prenatal licorice consumption was associated with lower cognitive performance, more ADHD symptoms, and pubertal changes in offspring. Low-level flavoring exposure (licorice candy in moderation) is likely distinct from concentrated root supplementation, but medicinal licorice root doses should be avoided.
• Red clover (Trifolium pratense): Isoflavones (biochanin A, formononetin) are phytoestrogenic; developmental exposure to exogenous estrogen-active compounds during organogenesis is a recognized concern. Avoid concentrated red clover extracts during the first trimester.

High-Dose Vitamin and Supplement Concerns

• High-dose biotin (>1,000 mcg): Biotin at supplemental doses above approximately 5,000 mcg interferes with immunoassay-based laboratory tests, including thyroid hormone (TSH, free T4), troponin, and hCG assays, by binding to the streptavidin used in the test architecture. The FDA issued a safety communication in 2017. Many "hair, skin, and nails" prenatal-adjacent supplements contain 5,000-10,000 mcg of biotin. This creates a risk of falsely reassuring (or falsely alarming) prenatal laboratory monitoring results. The prenatal biotin requirement is 30 mcg/day; supplemental doses above 1,000 mcg serve no established pregnancy benefit and create test interference risk.
• Melatonin: Melatonin is a hormone, not simply a sleep aid, and plays a role in circadian rhythm regulation and possibly placental function. There is no established safe supplemental dose in pregnancy, and the endogenous melatonin environment during pregnancy is already substantially different from the non-pregnant state. Avoid supplemental melatonin during pregnancy except under direct clinician guidance.
• Activated charcoal: Used in wellness contexts as a "detox" supplement. Activated charcoal non-selectively adsorbs compounds in the GI tract -- including vitamins, minerals, and medications. A prenatal vitamin taken concurrently with activated charcoal will have substantially reduced absorption of its nutrients. Activated charcoal also adsorbs medications including antiemetics and antibiotics. Do not use activated charcoal products during pregnancy or within four hours of taking a prenatal vitamin or any medication.

Herbs With Limited Data but Generally Regarded as Safer

• Ginger (Zingiber officinale): The most studied herbal intervention for pregnancy nausea and vomiting. Multiple randomized controlled trials and a Cochrane systematic review support efficacy for nausea and vomiting of pregnancy (NVP); doses of 1 gram per day divided across the day have been used in studies without documented adverse outcomes. Some guidelines suggest caution above 1-2 grams per day in the first trimester due to theoretical anticoagulant activity at very high doses, but the evidence base supports ginger as the best-documented herbal option for nausea in pregnancy.
• Red raspberry leaf (Rubus idaeus): Widely used in the third trimester with the traditional claim of preparing the uterus for labor. Limited but not alarming safety data; a 1999 retrospective study found no increased adverse outcomes with third-trimester use. There is insufficient evidence to recommend or advise against it; most practitioners take a neutral position on use in the third trimester at traditional tea doses, with avoidance in the first trimester.
• Peppermint leaf and chamomile (tea quantities): One to two cups of peppermint or chamomile tea daily is generally considered low-risk; both are used for nausea and digestive comfort in pregnancy. High-dose concentrated extracts or essential oils are a different matter. Stick to infused tea preparations at culinary quantities.

Getting the Most from Your Prenatal

Selecting a high-quality prenatal is a necessary first step. The following usage habits determine whether the chosen prenatal actually delivers its intended benefit and whether common reasons for abandonment can be addressed.

1. 01

   Start before conception

   Neural tube closure is complete by 28 days post-conception -- days 18-28 of fetal development. Most people do not confirm pregnancy until 4-6 weeks after the last menstrual period, which is 2-4 weeks after neural tube closure. For the folate supplementation to be present during the critical window, it must be taken before conception. Current guidance recommends starting at least one month before attempting conception; 1-3 months is optimal. Anyone who is not actively preventing pregnancy and is of childbearing age is generally recommended to take 400 mcg of folate or folic acid daily for this reason.

2. 02

   Take with food to manage iron side effects

   Iron is the ingredient most responsible for nausea, constipation, and dark stools that cause people to skip prenatal doses. Taking the prenatal with a small meal or snack significantly reduces GI irritation. Food also stimulates gastric acid secretion, which improves ferrous iron dissolution and absorption. If nausea is severe, taking the prenatal with dinner (rather than in the morning) can reduce symptom overlap with other first-trimester nausea triggers.

3. 03

   Separate calcium and iron supplementation by two hours

   Calcium directly inhibits non-heme iron absorption by competing for the same intestinal transport protein (DMT-1) and by reducing luminal acidity. If calcium is being supplemented separately (which is common because most prenatals provide insufficient calcium), it should be taken at a different meal than the prenatal iron -- at least two hours apart. For the same reason, taking a prenatal with a large glass of milk is counterproductive for iron absorption; water or juice is preferred.

4. 04

   Separate from coffee, tea, and high-tannin beverages

   Polyphenols in coffee, black tea, and green tea inhibit non-heme iron absorption by forming insoluble iron-polyphenol complexes in the gut. Studies quantify this inhibition at 40-60% for a cup of black tea consumed with a meal versus the same meal without tea. This is particularly important for iron-deficient individuals. Taking a prenatal with breakfast coffee or morning tea is a common habit that substantially reduces effective iron delivery. A gap of at least one hour between coffee or tea and the prenatal is a reasonable practical target.

5. 05

   Manage nausea before abandoning the prenatal

   Prenatal abandonment in the first trimester due to nausea is common and has clinical consequences. Before stopping, the following adjustments have evidence or reasonable rationale: (1) Switch to an evening dose with dinner; (2) Switch to a gummy prenatal as a temporary bridge, accepting the lack of iron and supplementing iron separately; (3) Switch to a bisglycinate iron form if the iron specifically is triggering nausea; (4) Ask the clinician about vitamin B6 supplementation at 10 mg three times daily for NVP -- supported by ACOG guidelines; (5) Discuss doxylamine-pyridoxine combination if B6 alone is insufficient. A prenatal taken consistently with suboptimal iron form is better than a perfect prenatal taken intermittently.

6. 06

   Address constipation specifically

   Iron-associated constipation during pregnancy is extremely common and frequently dismissed as inevitable. It is often manageable. Bisglycinate iron causes significantly less constipation than sulfate at equivalent doses. Adequate hydration (eight or more cups per day) and dietary fiber (25 g/day) reduce constipation risk. Docusate sodium (stool softener) is considered pregnancy-safe and can be used as needed. Stimulant laxatives (bisacodyl, senna) are generally considered second-line and should be discussed with a clinician for longer-term use during pregnancy. Magnesium glycinate or citrate (not oxide) can also support bowel regularity while contributing to the magnesium requirement -- an uncommon dual-use worth discussing with a clinician.

7. 07

   Continue through the postpartum and lactation period

   The popular perception that prenatal vitamins are only for pregnancy is incorrect. Nutritional depletion is most acute in the weeks and months after delivery -- iron stores are reduced by blood loss at delivery, DHA is transferred to breastmilk at the expense of maternal levels, iodine and choline requirements remain elevated through lactation, and vitamin D and folate needs continue. Many clinicians recommend continuing a prenatal or switching to a postpartum/lactation formula through the breastfeeding period. Postpartum formulas typically increase iodine to 290 mcg and often include DHA; they may provide less iron (appropriate if recovery is complete and diet is adequate) and should be selected based on the same third-party verification criteria as the prenatal itself.

Shopping Framework

The prenatal vitamin market rewards those who know what to look for and penalizes those who rely on marketing claims. The following tiers reflect the evidence on what actually distinguishes higher-quality prenatal supplements from lower-quality ones.

The Bottom Line

Sources

1. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat. 4325 (1994). Primary federal law governing dietary supplements including prenatal vitamins.
2. U.S. Government Accountability Office. (2023). Dietary Supplements: FDA Should Strengthen Oversight of Nutrient Claims and Amounts (GAO-23-105666). Washington, DC: GAO. Found 11 of 12 prenatal supplements deviated from label in at least one nutrient.
3. Wang, L., et al. (2024). Heavy metals, phthalates, and other contaminants in over-the-counter prenatal multivitamins. Environmental Research, 247, 118274. Detection rates: 83% lead, 73% cadmium, >25% phthalates.
4. MRC Vitamin Study Research Group. (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet, 338(8760), 131-137.
5. Czeisel, A.E., & Dudas, I. (1992). Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine, 327(26), 1832-1835.
6. Rothman, K.J., et al. (1995). Teratogenicity of high vitamin A intake. New England Journal of Medicine, 333(21), 1369-1373. 22,748-woman cohort; 4.8x cranial neural crest risk above 10,000 IU/day preformed retinol.
7. Bailey, R.L., et al. (2015). Estimated total usual intake of shortfall nutrients among U.S. adults. Journal of Nutrition, 145(7), 1692S-1698S. Choline and vitamin D inadequacy data.
8. Caudill, M.A., et al. (2018). Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study. FASEB Journal, 32(4), 2172-2180.
9. Ganz, A.B., et al. (2019). Deficiencies in docosahexaenoic acid and choline in prenatal vitamins: a public health concern. Nutrition Reviews, 77(1), 1-15. Found 92% of prenatals provided <55 mg choline vs. 450 mg target.
10. Afshar, Y., et al. (2021). Iodine deficiency in pregnancy and postpartum in the United States. American Journal of Obstetrics and Gynecology, 225(3), 327.e1-327.e7.
11. Miraglia del Giudice, E., et al. (2024). Comparison of ferrous bisglycinate, ferrous fumarate, and ferrous sulfate for iron deficiency in pregnancy: a randomized controlled trial. Journal of Pregnancy, 2024, 1-9.
12. Frosst, P., et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10(1), 111-113. MTHFR C677T polymorphism characterization.
13. Mills, J.L., et al. (2022). Folate status, MTHFR genotype, and neural tube defects: a systematic review. American Journal of Clinical Nutrition, 116(2), 342-359.
14. Armas, L.A., et al. (2004). Vitamin D2 is much less effective than vitamin D3 in humans. Journal of Clinical Endocrinology and Metabolism, 89(11), 5387-5391.
15. Saccone, G., et al. (2016). Efficacy of omega-3 long-chain polyunsaturated fatty acid supplementation for reducing risk of preterm birth: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 215(3), 304-316.
16. U.S. FDA. (2017). The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Washington, DC: FDA. Troponin and thyroid hormone assay interference at doses >5,000 mcg.
17. Ernst, E. (2002). Herbal medicinal products during pregnancy: are they safe? BJOG: An International Journal of Obstetrics and Gynaecology, 109(3), 227-235.
18. Dugoua, J.J., et al. (2006). Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation. Canadian Journal of Clinical Pharmacology, 13(3), e257-e261.
19. Raikkonen, K., et al. (2017). Maternal licorice consumption during pregnancy and pubertal, cognitive, and psychiatric outcomes in children. American Journal of Epidemiology, 185(5), 317-328.
20. Viljoen, E., et al. (2014). A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutrition Journal, 13, 20.
21. European Medicines Agency. (2014). Assessment report on Chelidonium majus L., herba. EMA/HMPC/322742/2013. Hepatotoxicity documentation.
22. California Legislature. (2025). Senate Bill 646 -- Prenatal Vitamins: Heavy Metal Testing and Disclosure. Signed October 2025, effective January 1, 2027. First state law requiring prenatal vitamin heavy-metal testing and public disclosure.
23. U.S. Food and Drug Administration. (2023). Current Good Manufacturing Practice (cGMP) Regulations for Dietary Supplements, 21 CFR Part 111. Governing framework for supplement manufacturing standards.
24. U.S. Pharmacopeia. (2024). USP Dietary Supplements Verification Program: Overview of Testing Standards. Rockville, MD: USP.
25. ConsumerLab.com. (2024). Product Review: Prenatal Multivitamins and DHA Supplements. Independent purchased-off-shelf testing and reporting including label accuracy and heavy metal results.
26. Clean Label Project. (2024). Prenatal Vitamin Purity Award Report: Testing Methodology and Results. 400+ contaminant panel results including phthalates, BPA, and heavy metals.